These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6275277)

  • 1. AQA 39*, a new bradycardic agent which blocks myocardial calcium (Ca) channels in a frequency- and voltage-dependent manner.
    Trautwein W; Pelzer D; McDonald TF; Osterrieder W
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):228-32. PubMed ID: 6275277
    [No Abstract]   [Full Text] [Related]  

  • 2. Interval- and voltage-dependent effects of the calcium channel-blocking agents D600 and AQA 39 on mammalian ventricular muscle.
    Trautwein W; Pelzer D; McDonald TF
    Circ Res; 1983 Feb; 52(2 Pt 2):I60-8. PubMed ID: 6299606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the mechanism of the "specific bradycardic action" of the verapamil derivative UL-FS 49.
    Doerr T; Trautwein W
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):331-40. PubMed ID: 1692108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The electrophysiological basis of the bradycardic action of AQA 39 on the sinoatrial node.
    Osterrieder W; Pelzer D; Yang QF; Trautwein W
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):233-7. PubMed ID: 6275278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirect stimulatory action of the calcium channel blocker AQA-39.
    Urthaler F; Walker AA
    J Pharmacol Exp Ther; 1984 Aug; 230(2):336-40. PubMed ID: 6747839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel block and recovery from block in mammalian ventricular muscle treated with organic channel inhibitors.
    Pelzer D; Trautwein W; McDonald TF
    Pflugers Arch; 1982 Aug; 394(2):97-105. PubMed ID: 6289260
    [No Abstract]   [Full Text] [Related]  

  • 7. AQ-A 39 (5,6-dimethoxy-2-[3[[alpha-(3,4-dimethoxy)-phenylethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heart.
    Kobinger W; Lillie C
    Eur J Pharmacol; 1981 Jun; 72(2-3):153-64. PubMed ID: 7250205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.
    Nakaya H; Tohse N; Takeda Y; Kanno M
    Br J Pharmacol; 1993 May; 109(1):157-63. PubMed ID: 7684298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent".
    Kobinger W; Lillie C
    Eur J Pharmacol; 1984 Sep; 104(1-2):9-18. PubMed ID: 6499920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of AQA39 on contractile performance of isolated mammalian ventricular myocardium.
    Sys SU; De Clerck NM; Brutsaert DL
    Eur J Pharmacol; 1984 Aug; 103(1-2):33-9. PubMed ID: 6479230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological influence of specific bradycardic agents on the pacemaker current of sheep cardiac Purkinje fibres. A comparison between three different molecules.
    Van Bogaert PP; Goethals M
    Eur Heart J; 1987 Dec; 8 Suppl L():35-42. PubMed ID: 3451881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic properties of falipamil (AQA-39)--a new bradycardiac agent.
    Lévy S; Mètge M; Hilaire J; Cointe R; Bru P; Eychenne JL; Gérard R
    Eur Heart J; 1987 Nov; 8(11):1236-40. PubMed ID: 3691560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a specific bradycardic agent (AQ-A39) and verapamil on beta-adrenergic responses in isolated guinea pig atria.
    Siegl PK; Morgan G
    Can J Physiol Pharmacol; 1987 Feb; 65(2):146-51. PubMed ID: 3032382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific bradycardic agents--a novel pharmacological class?
    Kobinger W; Lillie C
    Eur Heart J; 1987 Dec; 8 Suppl L():7-15. PubMed ID: 2897916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase action of ouabain on the electrical and contractile activity of the frog myocardium].
    Kitaĭgorodskaia GM; Mukumov MR; Dmitrieva NV
    Farmakol Toksikol; 1984; 47(1):38-44. PubMed ID: 6323213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New aspects of excitation-contraction coupling in cardiac muscle: two types of Ca++ entry promotion with and without involvement of cyclic AMP and Mg++ ions.
    Fleckenstein A; Späh F; Wagner WL; Frey M
    Basic Res Cardiol; 1987; 82 Suppl 2():233-50. PubMed ID: 2444204
    [No Abstract]   [Full Text] [Related]  

  • 17. Alinidine as a model of the mode of action of specific bradycardic agents on SA node activity.
    van Ginneken AC; Bouman LN; Jongsma HJ; Duivenvoorden JJ; Opthof T; Giles WR
    Eur Heart J; 1987 Dec; 8 Suppl L():25-33. PubMed ID: 3451880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular actions of 5,6-dimethoxy-2-(3-[(alpha-(3,4-dimethoxy) phenylethyl)-methylamino] propyl) phthalimidine (AQ-A 39), a specific bradycardic agent.
    Dämmgen J; Kadatz R; Diederen W
    Arzneimittelforschung; 1981; 31(4):666-70. PubMed ID: 7195712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the force-frequency relationship by tert-butylbenzohydroquinone, a putative SR Ca2+ pump inhibitor, in rabbit and rat ventricular muscle.
    Baudet S; Do E; Noireaud J; Le Marec H
    Br J Pharmacol; 1996 Jan; 117(2):258-67. PubMed ID: 8789377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of diltiazem on calcium transport and development of tension in heart muscle.
    Morad M; Tung L; Greenspan AM
    Am J Cardiol; 1982 Feb; 49(3):595-601. PubMed ID: 6277180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.